Nitric oxide has an important role in the regulation of airway function and
can have pro-inflammatory effects. Bronchial hyperresponsiveness (BHR) and
respiratory symptoms are common in patients with Sjogren's syndrome (SS),
The aim of this study was to determine whether patients with SS have an inc
reased amount of exhaled NO and whether this NO correlates with respiratory
symptoms and BHR,
Exhaled NO was measured in 18 patients with SS and 13 normal subjects on th
ree different occasions with intervals of at least 3 days using a chemilumi
nescence method. Airway responsiveness was assessed with methacholine provo
cation, Serum levels of myeloperoxidase (MPO), human neutrophil lipocalin (
HNL), eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO) wer
e measured.
Exhaled NO was significantly higher in patients with SS than in controls (1
47+/-82 versus 88+/-52 nL.min(-1;) mean+/-SD; p=0.041). Exhaled NO was corr
elated with age (partial r=0.52, p=0.006) and serum HNL (partial r=0.46, p=
0.014). There were no significant correlations between exhaled NO and respi
ratory symptoms, BHR or serum MPO, ECP or EPO, Disease duration was negativ
ely associated with serum MPO (r=-0.47, p=0.043), In patients with SS, a po
sitive correlation was found between symptom score and serum ECP (partial r
=0.65, p=0.003) and EPO (partial r=0.62, p=0.004) and a negative correlatio
n with age (partial r-0.60, p=0.005),
In conclusion, elevated levels of exhaled nitric oxide in patients with Sjo
gren's syndrome mere demonstrated, The mechanism underlying this increase i
n exhaled nitric oxide in Sjogren's syndrome is not known.